These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12794526)

  • 1. Comparison of PFA-100 and bleeding time testing in pediatric patients with suspected hemorrhagic problems.
    Cariappa R; Wilhite TR; Parvin CA; Luchtman-Jones L
    J Pediatr Hematol Oncol; 2003 Jun; 25(6):474-9. PubMed ID: 12794526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice.
    Posan E; McBane RD; Grill DE; Motsko CL; Nichols WL
    Thromb Haemost; 2003 Sep; 90(3):483-90. PubMed ID: 12958618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PFA-100 system: a new method for assessment of platelet dysfunction.
    Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
    Semin Thromb Hemost; 1998; 24(2):195-202. PubMed ID: 9579642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of PFA-100 testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time.
    Podda GM; Bucciarelli P; Lussana F; Lecchi A; Cattaneo M
    J Thromb Haemost; 2007 Dec; 5(12):2393-8. PubMed ID: 18034764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100 ): influence of hematocrit elevation.
    Escolar G; Cases A; Viñas M; Pino M; Calls J; Cirera I; Ordinas A
    Haematologica; 1999 Jul; 84(7):614-9. PubMed ID: 10406903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders.
    Favaloro EJ; Facey D; Henniker A
    Am J Hematol; 1999 Nov; 62(3):165-74. PubMed ID: 10539883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyser at high shear rates.
    Fressinaud E; Veyradier A; Sigaud M; Boyer-Neumann C; Le Boterff C; Meyer D
    Br J Haematol; 1999 Sep; 106(3):777-83. PubMed ID: 10468873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease.
    Schlammadinger A; Kerenyi A; Muszbek L; Boda Z
    Thromb Haemost; 2000 Jul; 84(1):88-92. PubMed ID: 10928476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the platelet function analyser (PFA-100) in the characterization of patients with von Willebrand's disease and its relationships with von Willebrand factor and the ABO blood group.
    Nitu-Whalley IC; Lee CA; Brown SA; Riddell A; Hermans C
    Haemophilia; 2003 May; 9(3):298-302. PubMed ID: 12694521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Platelet Function Analyzer-100 for Laboratory Detection of Anti-Platelet Drug-Induced Platelet Dysfunction.
    Kweon OJ; Lim YK; Kim B; Lee MK; Kim HR
    Ann Lab Med; 2019 Jan; 39(1):23-30. PubMed ID: 30215226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards 50 years of platelet function analyser (PFA) testing.
    Favaloro EJ; Pasalic L; Lippi G
    Clin Chem Lab Med; 2023 Apr; 61(5):851-860. PubMed ID: 35859143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a Platelet Function Analyser (PFA-100) in patients with a bleeding tendency.
    Wuillemin WA; Gasser Ka; Zeerleder SS; Lämmle B
    Swiss Med Wkly; 2002 Aug; 132(31-32):443-8. PubMed ID: 12457302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.
    Castaman G; Tosetto A; Goodeve A; Federici AB; Lethagen S; Budde U; Batlle J; Meyer D; Mazurier C; Goudemand J; Eikenboom J; Schneppenheim R; Ingerslev J; Habart D; Hill F; Peake I; Rodeghiero F
    Br J Haematol; 2010 Nov; 151(3):245-51. PubMed ID: 20738304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential supplementary utility of combined PFA-100 and functional von Willebrand factor testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand disease.
    Favaloro EJ; Thom J; Patterson D; Just S; Baccala M; Dixon T; Meiring M; Koutts J; Rowell J; Baker R
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):475-83. PubMed ID: 19584715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening women with menorrhagia for underlying bleeding disorders: the utility of the platelet function analyser and bleeding time.
    Philipp CS; Miller CH; Faiz A; Dilley A; Michaels LA; Ayers C; Bachmann G; Dowling N; Saidi P
    Haemophilia; 2005 Sep; 11(5):497-503. PubMed ID: 16128894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
    Giannini S; Mezzasoma AM; Leone M; Gresele P
    Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders.
    Kobrinsky NL; Israels ED; Gerrard JM; Cheang MS; Watson CM; Bishop AJ; Schroeder ML
    Lancet; 1984 May; 1(8387):1145-8. PubMed ID: 6144876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External quality assessment/proficiency testing and internal quality control for the PFA-100 and PFA-200: an update.
    Favaloro EJ; Bonar R
    Semin Thromb Hemost; 2014 Mar; 40(2):239-53. PubMed ID: 24497116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of increased von Willebrand factor levels on primary hemostasis in thrombocytopenic patients with liver cirrhosis.
    Wannhoff A; Müller OJ; Friedrich K; Rupp C; Klöters-Plachky P; Leopold Y; Brune M; Senner M; Weiss KH; Stremmel W; Schemmer P; Katus HA; Gotthardt DN
    PLoS One; 2014; 9(11):e112583. PubMed ID: 25397410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.